Reports for AVALIDE
Brand name
AVALIDE
Company Name
SANOFI-AVENTIS CANADA INC
|
Drug Identification Number
02241818 |
Ingredients
HYDROCHLOROTHIAZIDE IRBESARTAN |
Ingredient Strength
12.5 MG 150 MG |
ATC Code
C09DAC09DA C09DA |
ATC Descriptor
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| AVALIDE | 90 | Resolved | 2018-12-20 | 2019-02-27 | 70230 |
| AVALIDE | 90 | Resolved | 2019-10-09 | 2020-01-24 | 95800 |
| AVALIDE | 90 | Resolved | 2021-01-28 | 2021-03-20 | 132678 |
| AVALIDE | 90 | Resolved | 2025-11-27 | 2025-12-05 | 272585 |
Showing 1 to 4 of 4
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0